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I N T R O D U C T I O N  
IN THE past several years, the nature of the enzymic defect associated with phenylketo- 
nuria (PKU) has been well defined (JERVIS, 1947; UDENFRIEND and BESSMAN, 1953; 
WALLACE, MOLDAVE and MEISTER, 1957; MITOMA, AULD and UDENFRIEND, 1957 ; 
KAUFMAN, 1961). However, a direct relationship between the absence of phenylalanine 
hydroxylase in the liver and mental deficiency remains to be demonstrated. Hypotheses 
relating the biochemical defect to the disease generally invoke competitive inhibition 
of an enzyme system by increased concentrations of one or more metabolites of the 
alternative pathways of phenylalanine metabolism (KNOX, 1960; PERRY, 1962). 
One characteristic of PKU is the irreversibility of the mental defect when dietary 
therapy is instituted after infancy. These early years are a period of active myelination. 
The possibility that PKU involves abnormal lipid metabolism is strengthened by 
reports of demyelination associated with PKU (ALVORD, STEVENSON, VOGEL and 
ENGLE, 1950; SCHOLZ, 1957; POSER and BOGAERT, 1959; CROME, TYMMS and WOOLF, 
1962). Other cogent arguments for a lipid defect in this disease have been reviewed 
(KNOX, 1960, 1961). From the biochemical standpoint, a lipid disorder in PKU is 
suggested by the following: 
1. Phenylacetic acid, a metabolite of phenylalanine, is present in increased amounts 
in PKU serum. The activation of phenylacetic acid to phenylacetyl CoA has been 
demonstrated in human liver (MOLDAVE and MEISTER, 1957). More recently, acylation 
of ethanolamine with phenylacetic acid, presumably via the CoA derivative, has been 
demonstrated (COLODZIN, BACHUR, WEISSBACH and UDENFRIEND, 1963). 
2. The well known oxidation of w-phenyl fatty acids (KNOOP, 1904), together with 
the known reversibility of /3-oxidation (LYNEN, 1955), suggests that a phenyl fatty acid 
derivative such as phenylacetyl CoA may be lengthened by addition of 2-carbon units. 
3. Fatty acid synthesis via malonyl CoA requires an end group of acetyl CoA 
which can to some extent be substituted. For example, propionyl CoA results in the 
formation of odd-numbered fatty acids (HORNING, MARTIN, KARMEN and VAGELOS, 
1961 ; BRADY, BRADLEY and TRAMS, 1960; VAGELOS et al., 1961 ; WAKIL, 1961 ; HAJRA 
and RADIN, 1962). Also terminal branched-chain fatty acids are formed from branched- 
chain precursors (LENNARZ, 1961 ; HORNING et al., 1961 ; VAGELOS et al., 1961). 
These observations suggested that in PKU, w-phenyl fatty acids are formed as a 
result of an elevated phenylacetate concentration in the body. The derived fatty acids 
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might then form defective structural lipids or interfere with complex lipid synthesis 
and ultimately be reflected in abnormal function. 
The present study was directed at testing this hypothesis. As an arbitrary criterion 
it was taken that a I per cent level of co-phenyl groups in brain fatty acids would 
constitute a sufficient amount to support the hypothesis. Techniques were developed 
for detection of w-phenyl groups at this level in biological material. coo-Phenyl fatty 
acids were not detected in PKU or non-PKU brains. 
MATERIALS A N D  M F T H O D S  
Materials. Diethyl ether, petroleum ether (Skellysolve B, b.p. 67-68'), isopropenyl acetate 
(Carbide and Carbon Chemicals Co., New York), and 2-(2-ethoxyethoxy)ethanol (Matheson, 
Coleman and Bell, Norwood, Ohio) were redistilled before use. Benzoic acid, phenylacetic acid and 
phenylbutyric acid were recrystallized before use. Diazald (N-methyl-N-nitroso-p-toluenesulphon- 
amide) was obtained from Aldrich Chemical Co., Milwaukee. Methyl benzoate was purchased from 
Fisher Scientific Co., Pittsburgh, and gave a single peak on GLC. Standards for GLC were mixtures 
of commercial and synthetic methyl esters furnished by Dr. N. RADIN of this laboratory. For the 
unbranched, unsubstituted (normal) acids, the mixture included esters of C,, through C,, acids with 
the exception of Czl. The x-acetoxy methyl ester mixture contained acids with chain lengths of Cis, 
C,,,and C,,. Florisil was obtained from the Floridin Co., Tallahassee, Florida. Other chemicals 
were analytical reagent grade. 
TLC was done with silica gel G (Brinkmann Instruments Co., New York). Plates were developed 
in Skellysolve B-ether (3 : 1) and sprayed with aqueous alkaline bromthymol blue. Standards were 
authentic methyl stearate ( R ,  = 0-92), methyl a-hydroxy stearate ( R ,  = 0*40), and cholesterol (R, -- 
0.18). 
[3-'*C]Phenylalanine and [2-14C]phenylacetate were purchased from New England Nuclear Corp., 
Boston. 
The authors are indebted to Dr. R. ALLEN of the University of Michigan for a sample of frozen 
PKU brain (J.D., 18 yrs.) and for amino acid analyses, performed by Mr. R. SHAH. Two formalin- 
fixed PKU brain specimens (V.N., 26 yrs. and W.J., 2.5 yrs.) were kindly supplied by Dr. G. A.  
JERVIS of Letchworth Village, Thiels, N.Y. The formalin-fixed brain from a case of maple syrup 
urine disease (C.D., 17 months) was obtained from Dr. W. A. HAWK of the Cleveland Clinic. Other 
brains (T..B., 48 yrs, formalin-fixed and E.F., 33 yrs, fresh frozen) were obtained from the Department 
of Pathology, University of Michigan. 
Tsolation offatty acids. One g of brain containing approximately equal amounts of white and 
grey matter is homogenized in 19 ml of ch1oroform:methanol (2:l) and filtered through sintered 
glass with vacuum, and the residue is washed twice with 3 ml of the same solvent. The total chloro- 
form-methanol extract is washed with one-fifth its volume of water. The resulting lower layer is 
further washed with the same volume of water plus one-half this amount of methanol. The aqueous 
methanol upper layer is discarded. The lower phase is evaporated to near dryness on a rotary 
evaporator. To facilitate drying and to reduce splashing 10 ml of absolute ethanol are added and the 
evaporation is continued to dryness. 
Hydrolysis is carried out by refluring the lipid fraction in 20 ml of methanol and 4 ml of conc. 
HCI for 6 hr (HAJRA and RADIN, 1962), after which an equal volume of water is added. The cooled 
mixture is treated three times with 20 ml portions of ether. The ether is evaporated under a stream 
of nitrogen, and 20 ml of 95 % ethanol and I ml of 40 ;4 KOH are added to the residue. This mixture 
is heated for 2 hr at 80" (ALBRINK, 1959) in a closed screw-cap test tube. Water (5 nil) is added, and 
the solution is treated three times with 10 ml of Skellysolve B. Concentrated HC1 is added to pH 1 
(pH paper) and the fatty acids are extracted with ether. 
Oxidation offatty acids. Fatty acids from 0.5 g of brain in ether are dried with a stream of N? 
in a one-piece refluxing apparatus consisting of an 18 x 70 mm test tube sealed to a small condenser. 
One millilitre of water, 0.2 ml of 5 N-KOH, and 1 ml of 0.3 M-KMnO, are added. The mixture is 
heated to reflux with magnetic stirring for 4 hr. Additional 1 nd portions of KMnO, are added at  
15, 30. 60, 90 and 150 min to maintain the purple colour. 
The cooled mixture is acidified to pH 1 (pH paper) with conc. H,SO,. Sufficient sodium bi- 
sulphite is added to reduce the MnO, and excess KMnO,. Renzoic acid from the oxidation of o- 
phenyl fatty acids is extracted from the clear acidic solution with three 5 ml portions of ether. The 
ether solution is treated three times with 5 ml OF 1 N-KHCO,. The aqueous extract is acidified with 
conc. HCl and treated three times with 5 ml of ether. This final ether solution is dried over sodium 
sulphate. The sodium sulphate is washed with ether, and the combined ether solutions are evaporated 
to about 0.5 ml. 
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Methylation and gas-liquid chromatographjr of benzoate. The ether solution containing benzoic 
acid, along with other acidic materials from the oxidation mixture, is methylated with diazomethane 
(SCHLENK and GELLERMAN, 1960). DMP, conveniently used for fatty acid esterification (KISHIMOTO 
and RADIN, 1963), could not be used here because it did not methylate benzoic acid quantitatively 
with the conditions used. GLC was performed on a flame ionization gas chromatograph (Model 
609, F and M Scientific Corp., Avondale, Pa.). A portion of the resulting esters is chromatographed 
on a 36 x 1/8 in. 0.d. column containing 15 per cent DEGS on Gas Chrom Z (Applied Science 
Laboratories, Inc., State College, Pa.). One minute after injection into the column (pre-heated to 
50"). the temperature is raised 2.3" per min. The retention time of authentic methyl benzoate is 
approximately 7 min. 
Methylation and GLC of fatty acids. A portion of the brain total fatty acid fraction was meth- 
ylated with DMP. The normal and hydroxy esters were separated by TLC or a Florisil column 
(HAJRA and RADIN, 1962). The hydroxy acid methyl esters were acetylated with isopropenyl acetate 
(HAGEMEYER and HULL, 1949; KISHIMOTO and -DIN, 1963) prior to GLC. Radioactivity was 
measured with a Tri-Carb scintillation counter (Packard Instrument Co., LaGrange, Ill.). Samples 
were dissolved in 15 ml of toluene containing 0.4 per cent 2,5-diphenyloxazole and 0.01 per cent 
1,4-bis-2-(5-phenyloxazolyl)-benzene. All samples were corrected for quenching. 
RESULTS 
Recovery of benzoate from oxidation mixtures. Recovery oxidation experiments 
were carried out with phenylbutyric acid, phenylacetic acid, and palmitic acid as 
TABLE I.-RECOVERY OF BENZOIC ACID FROM THE OXIDATION 









phenylacetic acid, 524 pmoles 
phenylbutyric acid, 0.94 pmole 
phenylbutyric acid, 0.94 pmole + palimitic acid, 105 pmoles 
phenylbutyric acid, 0.94 pmole 
phenylbutyric acid, 0.94 pmole + palimitic acid, 144 pmoles 








a The ether extract from an oxidation mixture was dried, and the benzoic 
acid weighed. Yield = 32.7 mg; melting point, 113-120", mixed melting 
point 117-122"; melting point after recrystallization from water, 121-122". 
b A portion of the extracted oxidation product in 3 ml of methanol with 
0.01 ml of 12 N-HCI was read against a methanol-HC1 blank in a 10 mm 
quartz cuvette at 272 my, E ~ , ~  = 890 (for phenylbutyrate, 
model compounds. Best results for the oxidation of phenylbutyric acid were obtained 
by refluxing the compound in slightly more alkaline KMnO, than the 6 moles 
theoretically required for oxidation to benzoic acid and CO,. When palmitic acid 
was added to the oxidation mixture, somewhat more than the above amount of 
KMnO, was required for optimal conversion of phenylbutyric acid to benzoic acid. 
However, relatively little KMnO, was taken up by palmitate; this result indicates a 
preferential oxidation alpha to the phenyl group. This permitted a fairly complete 
oxidation of phenylbutyrate in the presence of 100-fold excess of palmitate. Sufficient 
KMnO, was added to maintain a purple colour in these experiments as well as those 
involving brain fatty acid and total lipid extracts. 
Yields of benzoate from the oxidation of phenylbutyrate ranged from 75 to 89 
per cent when analysed by GLC (Table 1). The range of recovery reflects variable 
losses during the oxidation. While ultraviolet analysis of oxidation mixtures gives 
comparable results, excessive amounts of chromogenic materials are introduced 
when tissue extracts are oxidized. While additional peaks were observed on GLC, 
= 29). 
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particularly when the oxidation mixtures contained fatty acids, they were not in the 
region of methyl benzoate and did not interfere with its measurement. 
Oxidation studies with human brain. PKU (V.N., W.J. and J.D.) and non-PKU 
(L.B.) brains were analysed by the above procedure. No trace of methyl benzoate 
was found; this result indicates the presence of less than 1 per cent coo-phenyl fatty 
acid in the fatty acid fraction of these brains. 
The possibility was considered that wphenyl groups are present in other lipid 
fractions. cu-Phenylalkylamines and ethers are possible lipids which would not be 
found in the fatty acid fraction. Chloroform-methanol extracts were oxidised with 
KMnO,. These crude extracts consumed more KMnO, (about 6.4 pmoles per g of 
brain) than the fatty acid fractions (1.8 pmoles per g of brain). An additional 0.1 ml 
of 5 N-KOH was added after 2 hr of reflux. Ether extracts from the oxidation mixture 
were methylated and subjected to GLC. Two formalin-fixed brains (V.N. and L.B.) 
yielded no methyl benzoate. The frozen non-PKU (E.F.) and frozen PKU (J.D.) 
brains contained 327 pg and 280 pg of methyl benzoate, respectively, per g of brain. 
Subsequently, the aqueous layer following acid hydrolysis of lipids from each of these 
brains was hydrolysed for 24 hr in 8 N-HCl. The amino acid analyses of this fraction 
indicated that a t  least 42 per cent of the methyl benzoate from non-PKU brain and 
70 per cent of the methyl benzoate from the PKU brain could be attributed to phenyl- 
alanine in proteolipid. 
In the light of all of the foregoing results, it is not probable that accumulation of 
cu-phenyl lipids is the cause of the reported demyelination or of the related mental 
deficiency in PKU. 
Fatty acid distribution in non-PKU and PKU brain. TLC of the methylated fatty 
acid preparations showed only two major spots corresponding to normal and M- 
hydroxy methyl esters. Occasionally, a faint spot was seen which had the R, of 
cholesterol. The use of DEGS for the GLC of the normal ester fraction permitted 
fairly complete resolution of oleic and stearic acid. 20:4 and 22: 5 were not separated 
from 22:O and 24:O respectively (JOHNSTON and KUMMEROW, 1960). In addition, 
22: 4 was not completely separated from 24: 0 + 22 : 5. Thegeneraldistribution pattern 
of fatty acids for brain is similar to the results reported for human brain by JOHNSTON 
and KUMMEROW (1960) although there is preliminary evidence suggesting a relative 
decrease in the ratio of oleic acid to stearic acid in PKU brain. No evidence of 
branched-chain fatty acids was found in the maple syrup disease brain. A unique 
fatty acid which accumulates in only one class of lipids could go undetected. 
The distribution of hydroxy acids does not indicate any pronounced differences 
between non-PKU and PKU brains. In each brain the C,, hydroxy acids comprised 
50-58 per cent of the total hydroxy acids by weight with 8-17 per cent distributed in 
each of the C,, and C,, fractions. 
In vivo studies with rat brain. Experiments were performed to measure the 
possible incorporation of labelled phenylalanine and phenylacetic acid into fatty acids. 
Fifteen-day-old rats were injected with 12-5 pc (0.6 mg) of [3-14C]phenylalanine 
HC1 either intraperitoneally or  intracranially. The animals were sacrificed after 19 hr 
and the fatty acids were extracted from brain and counted. In  each case, about 20,000 
disintegrations/min were obtained. GLC indicated that most of the activity was in 
palmitic acid. KMnO, oxidation released almost all of the radioactivity as CO,. These 
results are compatible with oxidation of phenylalanine in the liver regardless of the 
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route of injection, and subsequent incorporation of labelled acetate formed into fatty 
acids in the brain. Intracranial injection of a similar amount of sodium [2J4C]- 
phenylacetate resulted in the incorporation of one-tenth the amount of radioactivity 
into total fatty acids observed with phenylalanine. In each instance, radioactivity 
amounting to about one-half that in the fatty acids was found in the non-saponifiable 
lipid fraction. 
DISCUSSION 
The combined KMnO, oxidation, esterification and GLC appear sufficiently 
sensitive to detect small amounts of substances that yield benzoate upon oxidation. 
For example, 1 g of brain yields about 100 pmoles of fatty acids, and 1 pmole of 
benzoic acid could easily be detected in the oxidation products. 
Analytical studies of human brain as well as radioisotopic experiments in rats 
gave no evidence for the possibility that w-phenyl fatty acids are present in mammalian 
brain. The report of BENTLEY, RAMSEY, SPRINGER, DIALAMEH and OLSEN (1961) that 
radioactivity from phenylalanine is incorporated into coenzyme Q may partially 
explain the finding that radioactivity is incorporated into the non-saponifiable 
fraction. 
S U M M A R Y  
A method is described for the determination of w-phenyl fatty acids in biological 
material. The method was employed to establish whether or not the high concentration 
of phenylalanine or its metabolites causes the synthesis of abnormal lipids such as 
w-phenyl fatty acids which in turn might be related to the mental retardation of 
phenylketonuria. No w-phenyl fatty acids were found in three brains from phenyl- 
ketonuric individuals. 
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